Wall Street firms are increasingly using their own in-house insurance companies to purchase private investments. These affiliated insurers have accumulated $413 billion in such assets, raising concerns among regulators.
Insurance companies owned by asset managers and banks have become major buyers of private credit, real estate, and other illiquid investments. This trend allows Wall Street firms to deploy capital while generating fees.
Regulators are now trying to keep pace with the rapid growth of these affiliated investments. The scale of this market has created challenges for oversight and risk assessment.
The practice involves insurers purchasing securities issued by their parent companies or related entities. This creates a closed-loop system that ties the health of the insurer to the performance of its parent firm.
Critics argue this arrangement can obscure true risk exposure. If parent companies face financial trouble, their in-house insurers may also suffer, potentially threatening policyholder protections.
Supporters say these investments are carefully managed and meet regulatory standards. They argue the structure provides stable funding for long-term assets like infrastructure projects.
Regulatory agencies are reviewing whether existing rules adequately address the risks. Some are calling for stricter disclosure requirements and limits on these affiliated transactions.
The $413 billion figure represents a significant portion of the insurance market. How regulators respond could reshape Wall Street’s approach to private investing for years to come.
